Eutropics Overview
- Year Founded
-
2005

- Status
-
Private
- Employees
-
7

- Latest Deal Type
-
Angel
- Investors
-
2
Eutropics General Information
Description
Developer of a predictive diagnostic biomarker technology designed to predict patient response to specific chemotherapies. The company's technology specializes in advancing in vitro diagnostics tools and personalized medicine to diagnose and treat cancer and reduce unnecessary suffering, enabling physicians to detect cancerous cells.
Contact Information
Website
www.eutropics.comCorporate Office
- 767-C Concord Avenue
- Cambridge, MA 02138
- United States
Corporate Office
- 767-C Concord Avenue
- Cambridge, MA 02138
- United States
Eutropics Timeline
Eutropics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Angel (individual) | 21-Aug-2024 | Completed | Generating Revenue | |||
3. Angel (individual) | 18-Nov-2021 | Completed | Generating Revenue | |||
2. Grant | 01-Jan-2017 | $8.07M | Completed | Generating Revenue | ||
1. Grant | 01-Jan-2016 | $800K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Eutropics Patents
Eutropics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240425583-A1 | Methods and compositions related to mcl-1 and bim heterodimer antibodies | Pending | 26-Jul-2021 | ||
CA-3203105-A1 | Methods and compositions related to bcl2 and bim heterodimer antibodies | Pending | 22-Dec-2020 | ||
US-20240043529-A1 | Methods and compositions related to bcl2 and bim heterodimer antibodies | Pending | 22-Dec-2020 | ||
EP-3740757-A1 | Methods for predicting cancer drug responsiveness | Inactive | 18-Jan-2018 | ||
US-20200348280-A1 | Methods for predicting cancer drug responsiveness | Pending | 18-Jan-2018 | A61P35/00 |
Eutropics Signals
Eutropics Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
National Cancer Institute | Government | |||
MassVentures | Venture Capital | Minority |
Eutropics FAQs
-
When was Eutropics founded?
Eutropics was founded in 2005.
-
Where is Eutropics headquartered?
Eutropics is headquartered in Cambridge, MA.
-
What is the size of Eutropics?
Eutropics has 7 total employees.
-
What industry is Eutropics in?
Eutropics’s primary industry is Biotechnology.
-
Is Eutropics a private or public company?
Eutropics is a Private company.
-
What is Eutropics’s current revenue?
The current revenue for Eutropics is
. -
How much funding has Eutropics raised over time?
Eutropics has raised $350K.
-
Who are Eutropics’s investors?
National Cancer Institute and MassVentures have invested in Eutropics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »